Leg ulceration

After undergraduate training in Bristol and specialist training in Gloucestershire, London and Brighton, Manj Gohel started his post as a Consultant Vascular and Endovascular Surgeon in Cambridge University Hospitals in 2012. He has had a strong academic and clinical interest in the management of venous ulceration and complex venous disease since 2002. Manj was an investigator in the landmark ESCHAR and EVRA venous ulcer trials. He has also supervised several BSc, MD and PhD students. He is an Honorary Senior Lecturer at Imperial College London and holds and Associate Lectureship at the University of Cambridge. His main clinical interests is complex venous disease, including novel superficial venous interventions and deep venous stenting. He is currently the Honorary Secretary of the RSM Venous Forum Section.

Una is a Registered Nurse, District Nurse and Queen’s Nurse who has been involved in tissue viability clinical practice, education and research for over 20 years. Her background includes tissue viability specialist nursing, teaching undergraduate and post graduate nurses, contributing to a range of wound care research studies, researching judgement and decision making for wound care and campaigning to raise the profile of wound care. She is a reviewer for the Cochrane Wounds group, former Tissue Viability Society trustee and was instrumental in the creation of the Legs Matter campaign.

She has published widely on wound care, particularly in relation to leg ulceration. Una is now responsible for developing and delivering the new National Wound Care Strategy Programme (NWCSP) which has been commissioned by NHS England. The NWCSP aims to improve the quality of wound care provision across England by reducing unwarranted variation, improving safety and optimising patient experience and outcomes. It will achieve this through developing national evidence-based recommendations about:

• Clinical care and service provision;
• Use of existing data and data sources and the development of metrics to drive improvements in wound care outcomes;
• Commissioning of services and supply and distribution of wound care dressings and interventions;
• Workforce issues and the educational needs of all those involved in care delivery including patients, carers and non-clinical staff; and
• Identifying gaps where evidence synthesis and further primary research are needed.